Previously undescribed form of B-cell chronic lymphoid leukemia with IgA expression/secretion and lytic bone lesions

American Journal of Hematology

Volumn 55, Issue 4, 1997, Pages 208-211

  Dunphy, Cherie H ^a   Oza, Yagnesh V ^b   Skelly, Milton E ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Internal Medicine   (United States)

Author keywords

B cell chronic lymphoid leukemia; IgA; Osteolysis

Indexed keywords

AGED; ARTICLE; B CELL LEUKEMIA; BONE ATROPHY; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; COMORBIDITY; HUMAN; IMMUNOGLOBULIN PRODUCTION; OSTEOLYSIS; PRIORITY JOURNAL;

AGED; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN A; IMMUNOHISTOCHEMISTRY; LEUKEMIA, B-CELL, CHRONIC; MALE; OSTEOLYSIS;

EID: 0030751197     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199707)55:4<208::AID-AJH8>3.0.CO;2-W     Document Type: Article

References (21)

1. Chan JKC, Banks PM, Cleary ML, Delsol G, DeWolf-Peeters C, Falini B, Gatter KC, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Knowles DM, Mason DY, Meiller-Hermelink H-K, Pileri SA, Piris MA, Ralfkaier E, Stein H, Warnke RA: A revised European-American classification of lymphoid neoplasm proposed by the International Lymphoma Study Group. AJCP 103:543, 1995.
2. Koziner B, Kempin S, Passe S, Gee T, Good RA, Clarkson BD: Characterization of B-cell leukemias: A tentative immunomorphological scheme. Blood 56:815, 1980.
3. Azar HA, Hill WT, Osserman EF: Malignant lymphoma and lymphatic-leukemia associated with myeloma-type serum proteins. Am J Med 23:239, 1957.
4. Fiddes P, Penny R, Wells V, Rozenberg MC: Clinical correlations with immunoglobulin levels in chronic lymphatic leukemia. Aust NZ J Med 2:345, 1972.
5. Zlotnick A, Robinson E: Chronic lymphatic leukemia associated with macroglobulinemia. Isr J Med Sci 6:365, 1970.
6. Rundles RW, Coonrad EV, Arends T: Serum proteins in leukemia. Am J Med 16:842, 1954.
7. Brem TH, Morton ME: Defective serum gammaglobulin formation. Ann Intern Med 43:465, 1955.
8. Jim RTS, Reinhard EH: Agammaglobulinemia and chronic lymphocytic leukemia. Ann Intern Med 44:790, 1956.
9. Jim RTS: Serum gamma globulin levels in chronic lymphocytic leukemia. Am J Med Sci 234:44, 1957.
10. Prasd A: The Association of hypogammaglobulinemia and chronic lymphatic leukemia. Am J Med Sci 236:610, 1958.
11. Ultmann JE, Fish W, Osserman E, Gellhorn A: The clinical implications of hypogammaglobulinemia in patients with chronic lymphocytic leukemia and lymphocytic lymphosarcoma. Ann Intern Med 51:501, 1959.
12. Jandle JH, ed: "Blood. Textbook of Hematology." Boston: Little, Brown & Co, 1987.
13. Sweet DL Jr, Golumb HM, Ultmann JE: The clinical features of chronic lymphocytic leukemia. Clin Haematol 6:185, 1977.
14. McMillan P, Mundy G: Hypercalcemia and osteolytic bone lesions in chronic lymphocytic leukemia. Br Med J 281:1107, 1980.
15. Redmond J 3d, Stites DP, Beckstead JH, George CB, Casavant CH, Gandara DR: Chronic lymphocytic leukemia with osteolytic bone lesions, hypercalcemia, and monoclonal protein. Am J Clin Pathol 79: 616, 1983.
16. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of chronic (Mature) B and T lymphoid leukaemias. J Clin Pathol 42:567, 1989.
17. Geisler CH, Larsen JK, Hansen NE, Hansen MM, Christensen BE, Lund B, Nielsen H, Plesner T, Thorling K, Andersen E, Andersen PK: Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 78:1795, 1991.
18. Ikematsu W, Ikematsu H, Okamura S, Otsuka T, Harada M, Niho Y: Surface phenotype and Ig heavy-chain usage in chronic B-cell leukemias: Expression of myelomonocytic surface markers in CD5-chronic B-cell leukemia. Blood 83:2601, 1994.
19. Laungnen RH, Carey RM, Wills RW, Hess CE: Hypercalcemia associated with chronic lymphocytic leukemia. Arch Intern Med 1339: 1307, 1979.
20. Mundy GR, Raisz LG, Cooper R, Schechter GP, Salmon S: Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med 290:867, 1974.
21. Cassuto JP, Krebs BP, Vio G, Dujardin P, Masseyeff R: β2-microglobulin, a tumor marker of lymphoproliferative disorders. Lancet ii:108, 1978.